Potassium Chloride
From Anvita Health Wiki
Contents |
Indications
- prevention & treatment of hypokalemia
Contraindications
- severe renal impairment
- hyperkalemia
- severe tissue trauma
Dosage
- normal daily requirement
- intravenous:
- Tablets:
* 6.7 meq Kaon-Cl * 8 meq Klor-Con, Slow-K, Micro-K * 10 meq Kaon-Cl, Klor-Con, Klotrix, K-Tab, K-dur, Ten-K, * Micro-K * 20 meq K-Dur
Liquids:
- use liquid for patients with esophageal compression or delayed gastric emptying time
- 10%: (20 meq/15 mL) Cena-K, Kaochlor, Kay Ciel, Klorvess, Kaon (120 mL, 480 mL, 960 mL)
- 20%: (40 meq/15 mL) Cena-K, Kaon- Cl (120 mL, 480 mL) Powders:
- 15 meq/pack K-Lor
- 20 meq/pack Kato, Kay Ciel K-Lor, Klor-Con, Micro-K LS, Klorvess
- 25 meq/pack K-Lyte- Cl, Klor-Con
- Injection: 2 meq/mL (10 mL, 20 mL)
Pharmacokinetics
- well-absorbed after oral administration
- eliminated mainly by the kidneys
Adverse-effects
- common (> 10%)
- less common (1-10%)
- hyperkalemia, bradycardia, dyspnea, weakness, local tissue necrosis with extravasation, pain at site of injection
- uncommon (< 1%)
- other
Drug-interactions
- potassium-sparing diuretics in combination increase K+ levels
- ACE inhibitors in combination increase K+ levels
- no convincing evidence that anticholinergics increase risk of GI irritation by KCl
More General Terms
Additional Terms
Internet Database
References
- Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
- Kaiser Permanente Northern California Regional Drug Formulary, 1998
- Department of Veterans Affairs, VA National Formulary
- Prescriber's Letter 18(10): 2011 Potassium and Anticholinergic Drug Interaction Detail-Document#: [1] (subscription needed) [2]
